Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 05

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 % viruses bronchiolitis HRV HMPV hbov assay influenza hmpv 95 WU CAP asthma load hcov
2 respiratory virus severity strains ARI © sensitivity ILI hmpv infection CI wupyv pneumoniae exacerbations viral load hcovs
3 children influenza infants hadv aris inc. assays illness antibody ALRI recipients bacteria exacerbation RTI hcov-nl63
4 patients respiratory RSV species HPIV med culture influenza-like human metapneumovirus controls immunocompromised bacterial AECOPD AOM hcov-hku1
5 detected parainfluenza admission phylogenetic china virol detection pandemic infection odds transplant pathogens chronic hbov1 human coronaviruses
6 study human unit HRV-C seasonal J. PCR H1N1 metapneumovirus ratio kipyv mycoplasma RV rtis HKU1
7 infections respiratory syncytial virus disease severity EV-D68 countries bocavirus rapid influenza-like illness vaccine adjusted KI pneumonia COPD media hcov-oc43
8 infection syncytial intensive genotypes peaks human bocavirus sensitive 2009 tract odds ratio polyomaviruses mycoplasma pneumoniae de otitis NL63
9 = adenovirus levels hrvs seasonality wiley RT-PCR illnesses review interval polyomavirus atypical atopic URI hcov-229e
10 samples respiratory viruses clinical sequences health periodicals specificity influenza‐like elderly confidence patients influenzae asthmatic RSV-A coronaviruses
11 clinical metapneumovirus disease phylogenetic analysis acute respiratory infections wiley‐liss conventional surveillance vaccines confidence interval HSCT streptococcus obstructive - 229E
12 viruses viral hospitalization HRV-A years RT‐PCR multiplex RSV les regression WUV community-acquired asthma exacerbations material staff
13 years coronavirus longer sequencing developing countries hbov infection test influenza‐like illness family logistic bronchoalveolar community-acquired pneumonia stable SUPPLEMENTARY coronavirus
14 symptoms rhinovirus PICU gene temperature hmpv method SARI pathogenesis LRTD BAL streptococcus pneumoniae wheezing online neonates
15 common human metapneumovirus hospital analysis artis tract ® outpatients igg maternal hematopoietic antibiotic chronic obstructive pulmonary disease quantitative saudi
16 chain parainfluenza virus oxygen sequenced year human xtag participants fusion hiv-infected HCT haemophilus el users residents
17 hospitalized influenza a stay sequence HPIV-3 hcov‐nl63 diagnostic epidemic suggests associated with cancer M. airway authorized OC43
18 reaction influenza virus acute bronchiolitis genome hpivs 2005 designed a(h1n1)pdm09 CNS risk transplantation haemophilus influenzae RV-C ELECTRONIC hcov infection
19 age type rsv infection genotype meteorological hbov. conventional methods elderly shown HIV KIV S. rhinovirus online version AGE
20 2 molecular factors hadv-7 patterns DNA clinical specimens sentinel été aor stem antibiotics los supplementary fecal
21 respiratory viruses RSV intensive care unit strain incidence parvovirus developed sore protection AFE lavage bacterial infection cystic fibrosis version fecal samples
22 positive coronaviruses length hadv-55 highest npas detect sore throat immunity 95%CI failure community‐acquired fibrosis acute otitis media hcov infections
23 tested parainfluenza viruses outcome isolates age hrsv DFA transmission host % cell filmarray allergic surgery pilgrims
24 specimens including coinfection genetic distribution co‐infections fast outpatient hmpv infections RV LRTI respiratory pathogens cystic KD hcov-nl63 infection
25 polymerase rhinoviruses duration region ALRTI hbov-positive antigen week biology multivariable bronchoalveolar lavage community‐acquired pneumonia sputum MATERIAL rotavirus
26 viral agents severe human rhinoviruses public real‐time real-time definition immune RV‐A wu virus bacterial pathogens en viral gastroenteritis
27 cases infections care diversity prevention hbov dna clinical samples symptom humans TB malignancy s. pneumoniae CRS ear households
28 PCR influenza viruses viral EV‐D68 epidemiological acute wheezing viral culture adults recent FLU wu polyomavirus catarrhalis RV-A middle arabia
29 results bocavirus higher HEV rural causative performance non-influenza development 1000 CMV H. rhinitis VRI mers-cov
30 group adenoviruses single VP1 5 agent seeplex alris studies population-based lung febrile asthmatics nasopharynx saudi arabia
31 1 enterovirus admitted ON1 summer children RT-LAMP individuals includes .001 organ chlamydia subjects article NH
32 identified detection = HRV-B humidity × RVP influenza virus paramyxoviridae HRV/ENT malignancies m. pneumoniae CP‐COPD OME human coronavirus
33 frequently influenza b infection identified HPIV-4 hcov‐hku1 specimens ilis dans AF mortality cultures acute exacerbations loads middle east respiratory syndrome coronavirus
34 acute influenza a virus compared nucleotide understood recently diagnosis training myocarditis fvdes hematologic chlamydophila ifn-γ complicating hajj
35 frequent common score partial data causative agent accurate influenza c virus lower hiv-uninfected neutropenia mp asthma exacerbation probiotics hcov species
36 rate detected children enterovirus worldwide hbov infections IFA adult virus nepal LRT chlamydophila pneumoniae se NPA hpev
37 detection viral etiology ventilation hexon annual acute laboratories active surveillance discovered pneumonia allogeneic pathogen PLT hpyv6 kenya
38 12 A/B syncytial showed RSV samples vial influenza c immune response hospitalization lung transplant infectious con psps staff members
39 tract % parameters serotype surveillance wheezing mrt-pcr season simplex control ribavirin aetiology acute asthma RNA hcov.
40 conclusions rhinovirus/enterovirus ICU clade public health hcov‐oc43 agreement women respiratory-tract case-control study oncology moraxella catarrhalis CFLI presence norovirus
41 frequency diagnostics respiratory syncytial virus hadv-3 years old pulmonol positive pregnant des hazard ratio CHD h. influenzae niños low hcov nl63
42 virus 1–4 months types rainy found maripoc virus hmpv-associated life-threatening disease leukemia staphylococcus por high NRVI
43 11 respiratory virus infections viral coinfection hadv infection human parainfluenza viruses pediatr pulmonol samples headache measles virus-virus polyomaviruses ki chlamydia pneumoniae allergic rhinitis 018 astrovirus
44 18 coronavirus oc43 mechanical rhinoviruses seasonal patterns multiplex rt‐pcr duplex PIV à rural thailand hematopoietic stem cell transplant assessment acute exacerbation PCR/ESI-MS NVRI
45 aim MPV associated with VP4/VP2 hpiv nasopharyngeal one‐step data human A/H3 hematologic malignancy bacterium pacientes rhinovirus rna hcov oc43
46 9 influenza virus a mechanical ventilation hrv-positive guangzhou 2003–2004 probes mpcr respiratory tract RV‐C tract pneumophila OSA MEE rotaviruses
47 25 acute lower molecular MP genotype b rt-pcr assays pregnant women infections CAAP EBV HCAP AE‐COPD quantitative pcr ltcfs
48 and/or b viruses mxa hadvs % hbovs specific control enzyme immunoassay adjusting HM ACS attacks otitis media SETTING
49 difference flua infants hospitalized typing children lower RT-PCR/ESI-MS patients respiratoires compared days PSI adenotonsillar 017 RT-PCR
50 presentation multiplex rt-pcr < NA1 seasonal peaks enteric viruses PRV KCDC EIA factors lower bacterial pathogen pulmonary asymptomatic npss